ATC Group: R06AD Phenothiazine derivatives

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R06AD in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R06 Antihistamines for systemic use
3 R06A Antihistamines for systemic use
4 R06AD Phenothiazine derivatives

Group R06AD contents

Code Title
R06AD01 Alimemazine
R06AD02 Promethazine
R06AD03 Thiethylperazine
R06AD04 Methdilazine
R06AD05 Hydroxyethylpromethazine
R06AD06 Thiazinam
R06AD07 Mequitazine
R06AD08 Oxomemazine
R06AD09 Isothipendyl
R06AD52 Promethazine, combinations
R06AD55 Hydroxyethylpromethazine, combinations

Active ingredients in R06AD

Active Ingredient Description
Alimemazine

Alimemazine has a central sedative effect, comparable to that of chlorpromazine, but largely devoid of the latter’s antiadrenaline action. It has powerful antihistamine and anti-emetic actions. Alimemazine is used to treat neurosis, depression and anxiety of different origins. It prevents and relieves allergic conditions, which cause pruritus and urticaria by blocking histamine produced by the body during an allergic reaction. Alimemazine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding.

Isothipendyl
Mequitazine

Mequitazine is a phenothiazine derivative with the actions and uses of antihistamines. Antihistamines diminish or abolish the main actions of histamine in the body by competitive, reversible blaockade of histamine receptor site on tissues; they do not inactivate histamine or prevent its synthesis or release. Antihistamines are used for palliative treatment of allergic reactions.

Oxomemazine
Promethazine

Promethazine is a potent, long acting, antihistamine with additional anti-emetic central sedative and anti-cholinergic properties.

Thiethylperazine

Related product monographs

Title Information Source Document Type  
AVOMINE Tablet Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
PHENERGAN Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PHENERGAN Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
PRIMALAN Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SOMINEX Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC